Consort Medical plc is pleased to announce that its Bespak division has extended one of its largest
commercial inhaler valve contracts for a further five years, which will secure around a third of its valve volumes.
Joe Barry, Managing Director of Bespak, said: “We greatly value the deep, long term relationships that we have with our customers. We are delighted to have renewed this important contract, which underlines our leading position in our market place and which acts as a platform for us to continue adding value to our current product offering and diversifying our range into new markets.”
Bespak is the world’s leading drug delivery device manufacturer for the respiratory market. It manufactures around 35% of the metered dose inhaler valves used by an estimated 300 million sufferers of asthma and Chronic Obstructive Pulmonary Disease (COPD) world-wide.